Verdiperstat

Verdiperstat is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Verdiperstatum. Its PubChem CID is 11528958.

CAS No 890655-80-8
Molecular Formula C11H15N3O2S
Molecular Weight 253.32 g/mol
Synonyms 1-(2-propan-2-yloxyethyl)-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one

Frequently Asked Questions